Wang Reflects on Ibrutinib’s Role and Emerging Research in MCL Management
Season 6, Episode 27, Jan 20, 2022, 10:33 PM
Dr Wang discusses the clinical experience with ibrutinib in mantle cell lymphoma, its present role in the management of MCL, and ongoing research that may affect its use as a single agent.